Epidermic necrolysis: Advances in pathogenesis;Necrolyse epidermique: Les avancees physiopathogeniques

Annales de Dermatologie et de Venereologie

Volumn 127, Issue 5, 2000, Pages 546-547

  Roujeau, J C ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; FAS ANTIGEN; FAS LIGAND; PHENYTOIN; SULFONAMIDE; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA; FASLG PROTEIN, HUMAN; LIGAND; MEMBRANE ANTIGEN; MEMBRANE PROTEIN;

ARTICLE; CYTOTOXIC T LYMPHOCYTE; DRUG MECHANISM; HUMAN; KERATINOCYTE; PATHOPHYSIOLOGY; TOXIC EPIDERMAL NECROLYSIS; TREATMENT INDICATION; ADULT; APOPTOSIS; CD8+ T LYMPHOCYTE; MACROPHAGE; PHYSIOLOGY; STEVENS JOHNSON SYNDROME;

ADULT; ANTIGENS, CD95; ANTIGENS, SURFACE; APOPTOSIS; CD8-POSITIVE T-LYMPHOCYTES; EPIDERMAL NECROLYSIS, TOXIC; FAS LIGAND PROTEIN; HUMANS; LIGANDS; MACROPHAGES; MEMBRANE GLYCOPROTEINS; STEVENS-JOHNSON SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034186567     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Paul C, Wolkenstein P, Adle H, Wechsler J, Revuz J, Roujeau JC. Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis and Stevens-Johnson syndrome. Br J Dermatol 1996;134:710-4.
2. Wolkenstein P, Latarjet J, Roujeau JC, Duguet C, Boudeau S, Vaillant L et al. Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis. Lancet 1998;352: 1586-9.
3. Viard I, Wehrli P, Bullani R, Schneider P, Holler N, Solomon D et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 1998;282:490-3.
4. Mauri-Hellweg D, Bettens F, Mauri D, Brander C, Hunziker T, Pichler WJ. Activation of drug-specific CD4+ and CD8+ cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine. J Immunol 1995;155:462-72.
5. Flageul B, Paul C, Wolkenstein P, Revuz J, Dubertret L, Roujeau JC. Etude de l'expression des molécules médiant l'apoptose dans les taxidermies. Ann Dermatol Venereol 1997;124: S49-S50.